These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19783047)

  • 1. Right and left shifts for age in MDS.
    Paydas S
    Leuk Res; 2010 Apr; 34(4):409-10. PubMed ID: 19783047
    [No Abstract]   [Full Text] [Related]  

  • 2. Young age MDS: differences between Western and Eastern countries.
    Paydas S
    Leuk Res; 2006 Mar; 30(3):362. PubMed ID: 16125229
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prospective clinical study of diagnosis and classification for 282 cases with primary myelodysplastic syndrome].
    Wang XQ;
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):546-9. PubMed ID: 17172130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelodysplastic syndromes (MDS) in Central Africans.
    Mukiibi JM; Paul B
    Trop Geogr Med; 1994; 46(1):17-9. PubMed ID: 8165730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of deletion of the long arm of chromosome 20 in patients with myelodysplastic syndrome (MDS): a study of the Greek MDS Study Group.
    Galanopoulos AG; Symeonidis A; Kourakli A; Papadaki EA; Tsaftaridis P; Terpos E; Aktipi A; Roussou P; Protopappa M; Pappaioannou M; Zikos P; Speletas M; Parcharidou A; Laoutaris N; Anagnostopoulos NI; Meletis J; Pangalis GA; Zoumbos N; Viniou N;
    Eur J Haematol; 2007 Jan; 78(1):89-90. PubMed ID: 17302860
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytogenetics of myelodysplastic syndromes].
    Laï JL; Fenaux P
    Pathol Biol (Paris); 1997 Sep; 45(7):550-5. PubMed ID: 9404478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
    Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C
    Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelodysplastic syndromes (MDS): the current landscape.
    Peskin SR
    Manag Care; 2009 Nov; 18(11 Suppl 9):2-3. PubMed ID: 20085110
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidemiology of myelodysplastic syndromes.
    Strom SS; Vélez-Bravo V; Estey EH
    Semin Hematol; 2008 Jan; 45(1):8-13. PubMed ID: 18179964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of MDS subtypes in Shanghai, China: a comparison of the World Health Organization and French American British classifications.
    Irons RD; Wang X; Gross SA; Bao L; Ryder J; Chen Y; Chen H; Sun H; Zhou J; Ji M; Du X; Fu H; Lin G
    Leuk Res; 2006 Jul; 30(7):769-75. PubMed ID: 16337268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome.
    Ishii Y; Hsiao HH; Sashida G; Ito Y; Miyazawa K; Kodama A; Ohyashiki JH; Ohyashiki K
    Cancer Genet Cytogenet; 2006 Jun; 167(2):131-7. PubMed ID: 16737912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis?
    Sieglová Z; Zilovcová S; Cermák J; Ríhová H; Brezinová D; Dvoráková R; Marková M; Maaloufová J; Sajdová J; Brezinová J; Zemanová Z; Michalová K
    Leuk Res; 2004 Oct; 28(10):1013-21. PubMed ID: 15289012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic characteristics of patients with signs and symptoms of myelodysplastic syndromes in the State of Pará, Brazil.
    Pinto GR; Overal DJ; Moraes LS; Van Den Berg AV; Lemos JA; Smith Mde A; Burbano RR
    Genet Mol Res; 2005 Mar; 4(1):18-30. PubMed ID: 15841432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The myelodysplastic syndromes.
    Nguyen PL
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):675-91. PubMed ID: 19577164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions.
    Valent P; Horny HP
    Eur J Clin Invest; 2009 Jul; 39(7):548-53. PubMed ID: 19453651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients.
    Maschek H; Georgii A; Kaloutsi V; Werner M; Bandecar K; Kressel MG; Choritz H; Freund M; Hufnagl D
    Eur J Haematol; 1992 Apr; 48(4):208-14. PubMed ID: 1592101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A feature of hematological findings in myelodysplastic syndromes].
    Bando S; Niiya T; Murase M; Makino H
    Rinsho Byori; 1998 Aug; 46(8):790-5. PubMed ID: 9760831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes.
    Bacher U; Haferlach T; Kern W; Weiss T; Schnittger S; Haferlach C
    Cancer; 2009 Oct; 115(19):4524-32. PubMed ID: 19569249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique cytogenetic features of primary myelodysplastic syndromes in Chinese patients.
    Li L; Liu XP; Nie L; Yu MH; Zhang Y; Qin TJ; Xiao ZJ
    Leuk Res; 2009 Sep; 33(9):1194-8. PubMed ID: 19128829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Etiological factors of myelodysplastic syndromes].
    Nisse C
    Pathol Biol (Paris); 1997 Sep; 45(7):539-44. PubMed ID: 9404476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.